Skip to main content
Caplight Logo









Ingenix

Ingenix

Private
WarsawHealthcare & Life Scienceshttps://ingenix.ai/

Last Round

Seed

Jun 3, 2026

Total Funding Raised

$25.04M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Ingenix is a biotechnology, artificial intelligence (AI), and software as a service (SaaS) company that provides a generative AI co-pilot for simulating clinical trials.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Drug Discovery, Medical AI

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Foundation

Keywords

clinical trial simulationin-silico trialsAI co-pilotBiological Reasoning Enginemultimodal AIAI for pharmadrug development AIgenerative AIclinical outcome predictionModality Fusionclinical trial digital twinAI foundation modelbiotech AIcomputational biologyadverse event predictiondrug discovery AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Ingenix Comparables

Compare Ingenix with similar companies based on industry and business-model similarity.

Ingenix comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
QuantHealth
87%
InSilicoTrials Technologies
85%
Unlearn
81%

Ingenix Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJun 3, 2026
SeedApr 9, 2025

Key People

Founding team and executive leadership

Piotr Surma

CEO

Executive Team

Ingenix Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 23, 2026

    Grew 18% QoQ, from 33 to 39 employees.

  • Jun 3, 2026

    $15M round led by Sofinnova Partners

Ingenix Filings

Explore SEC and related filing metadata, where available.

Ingenix filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Ingenix's valuation, stock price, and market status.

Is Ingenix a public or private company?

Ingenix is a private company.

What is the current stock price of Ingenix?

Ingenix is a private company with no public stock price. No recent secondary market data is available.

How much is Ingenix worth (valuation)?

Valuation information for Ingenix is not publicly available.

Can I buy Ingenix stock?

Ingenix shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Ingenix's last funding round?

Ingenix's most recent funding round was Seed on June 3, 2026.

Who are the main investors in Ingenix?

Key investors in Ingenix include Inovo Venture Partners, Sofinnova Partners.

Will Ingenix IPO soon?

No public IPO plans have been announced for Ingenix.

How can I track Ingenix secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Ingenix's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersWarsaw
Employee Range31
Year Founded2023
Last FundingJun 3, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?